Business in the Burbs

EpiCept to seek approval of leukemia treatment

February

EpiCept Corp., a Tarrytown-based biotech company, said that it hopes to file an application seeking U.S. regulatory approval for Ceplene, a new leukemia treatment, during the second half of 2009. That followed an announcement in December that EpiCept had received permission from Canadian authorities to submit an application for approval of the drug. EpiCept said regulators are expected to make decisions on the drug applications in 2010.

This entry was posted on Monday, February 2nd, 2009 at 1:49 pm by Jay Loomis.
You can follow any responses to this entry through the RSS 2.0 feed.
Print | Email

It is a condition of your use of the comment features associated with the blogs that you do not: Use the site to post or transmit any unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane or indecent information of any kind, including without limitation any transmissions constituting or encouraging conduct that would constitute a criminal offense, give rise to civil liability or otherwise violate any local, state, national or international law. You alone are responsible for the material you post or send. Refer to the Terms of Service.